STAT

STAT+: Oncologists turn to blood test for circulating tumor DNA, but questions remain on how to use the data

A blood test known as a ctDNA test can be a good indicator of whether someone's cancer will return after surgery. But the test doesn't always clarify the next step…
Source: Adobe

The hope for many cancer patients who go through surgery is that they’ll be cured after the surgeon removes the tumor. The question

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Don’t Write Off MDMA Yet: How The FDA Got On Board With Psychedelics
Psychedelic evangelists have been working to win over regulators since the 1980s, and those relationships helped persuade the FDA to sign off on research.
STAT1 min read
STAT+: How Controversial Was The Decision By FDA’s Peter Marks To Approve Sarepta’s Gene Therapy? Check Its Footnotes
The unilateral decision by Peter Marks, a top FDA official, to approve a gene therapy for Duchenne muscular dystrophy looks even more surprising on a close examination.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Moderna Covid-flu Vaccine, A Paused Pfizer Study, And More
Moderna announced its combination Covid and flu vaccine generated stronger immune responses in older adults in a Phase 3 trial than individual vaccines.

Related Books & Audiobooks